A Paradigm Shift—Adaptable/Disposable Versus Legacy Laboratory Facilities—Which is the More Sustainable Solution?
Lois Rosenblum, S/L/A/M Collaborative
Gary Annino, Pfizer, Inc.
In the brave, new, and flat world of global competition, corporations engaged in research and development are rapidly shifting how facilities are designed and valued. The need to be nimble is a must, as companies have to be able to adapt and respond quickly to changes in both global markets and rapid technological advances. In order to expedite return on investment, facilities now need to be readily adaptable or replaceable and disposable so that more productive initiatives can be leveraged. During this presentation, the speakers will explore these challenges. The speakers will also discuss how this shift has affected Pfizer Inc's approach to the design and development of new research facilities, and how it has led Pfizer to a more sustainable footprint—one that examines operating cost, square foot per researcher, square foot per cost, and productivity impacts of compression.
Biography:
Gary Annino is the director, global procurement and operations, at Pfizer Inc.
Mr. Annino started his career at Pfizer as an engineer. He championed the installation of a 10 megawatt Gas Turbine with an annual site savings (net) of approximately $4.5 million. During the cessation of manufacturing in Groton, Mr. Annino structured and implemented the Site Remediation and Demolition Program. Mr. Annino joined the Global Operations Team in 2008 as the director for the Facilities Solutions Team in the middle of the Ann Arbor consolidation effort. Mr. Annino is responsible for managing and directing Pfizer's facilities planning and capital project delivery services, working closely with the research and development and commercial customers across the Americas to identify opportunities for great partnership and innovate ways to increase productivity.